Search research articles
Contact Us
Filters
Showing results (21-30 of 85) with videos related to
Page
of 9
Sort By:
Gynecologic Oncology
|
September 8, 2004
Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma
Adam Shapiro, Alex Ferenczy, Robert Turcotte, et al.
Journal of Chemotherapy (Florence, Italy)
|
April 20, 2016
Analysis of two topotecan treatment schedules in patients with recurrent ovarian cancer
Ilan Bruchim, Zipi Ben-Harim, Ettie Piura, et al.
Archives of Gynecology and Obstetrics
|
March 9, 2013
Preoperative clinical and radiological features of metastatic ovarian tumors
Ilan Bruchim, Zipi Ben-Harim, Ettie Piura, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
October 8, 2021
Increased incidence with improved survival of gynecologic carcinosarcoma: A population-based study
Lina Salman, Yana Brudner, Barbara G Silverman, et al.
Gynecologic Oncology
|
February 8, 2011
Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines
Zohar Attias-Geva, Itay Bentov, Ami Fishman, et al.
Maturitas
|
November 5, 2021
High incidence of gynecologic sarcomas in Israel-A comparison to European and American reports: Gynecologic Sarcoma in Israel
Yana Brudner, Lina Salman, Gabi Haran, et al.
Frontiers in Endocrinology
|
June 21, 2018
The Role of the Insulin-Like Growth Factor 1 Pathway in Immune Tumor Microenvironment and Its Clinical Ramifications in Gynecologic Malignancies
Muna Alemi Yahya, Shilhav Meisel Sharon, Shay Hantisteanu, et al.
Molecular and Cellular Endocrinology
|
February 21, 2015
Proliferative and signaling activities of insulin analogues in endometrial cancer cells
Daniel Aizen, Rive Sarfstein, Ilan Bruchim, et al.
Critical Reviews in Oncology/Hematology
|
December 26, 2006
Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
Patrick Petignat, Andreas du Bois, Ilan Bruchim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 22, 2016
High Efficacy and Low Toxicity of the Modified Docetaxel and Carboplatin Protocol in Patients with Recurrent Ovarian Cancer-A Phase 2 Cohort Study
Ilan Bruchim, Natalie Weeg, Yoav Alpert, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 85) with videos related to
Sort By:
Page
of 9
Gynecologic Oncology
|
September 8, 2004
Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma
Adam Shapiro, Alex Ferenczy, Robert Turcotte, et al.
Journal of Chemotherapy (Florence, Italy)
|
April 20, 2016
Analysis of two topotecan treatment schedules in patients with recurrent ovarian cancer
Ilan Bruchim, Zipi Ben-Harim, Ettie Piura, et al.
Archives of Gynecology and Obstetrics
|
March 9, 2013
Preoperative clinical and radiological features of metastatic ovarian tumors
Ilan Bruchim, Zipi Ben-Harim, Ettie Piura, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
October 8, 2021
Increased incidence with improved survival of gynecologic carcinosarcoma: A population-based study
Lina Salman, Yana Brudner, Barbara G Silverman, et al.
Gynecologic Oncology
|
February 8, 2011
Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines
Zohar Attias-Geva, Itay Bentov, Ami Fishman, et al.
Maturitas
|
November 5, 2021
High incidence of gynecologic sarcomas in Israel-A comparison to European and American reports: Gynecologic Sarcoma in Israel
Yana Brudner, Lina Salman, Gabi Haran, et al.
Frontiers in Endocrinology
|
June 21, 2018
The Role of the Insulin-Like Growth Factor 1 Pathway in Immune Tumor Microenvironment and Its Clinical Ramifications in Gynecologic Malignancies
Muna Alemi Yahya, Shilhav Meisel Sharon, Shay Hantisteanu, et al.
Molecular and Cellular Endocrinology
|
February 21, 2015
Proliferative and signaling activities of insulin analogues in endometrial cancer cells
Daniel Aizen, Rive Sarfstein, Ilan Bruchim, et al.
Critical Reviews in Oncology/Hematology
|
December 26, 2006
Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
Patrick Petignat, Andreas du Bois, Ilan Bruchim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 22, 2016
High Efficacy and Low Toxicity of the Modified Docetaxel and Carboplatin Protocol in Patients with Recurrent Ovarian Cancer-A Phase 2 Cohort Study
Ilan Bruchim, Natalie Weeg, Yoav Alpert, et al.
Page
of 9